OneMedNet (NASDAQ:ONMD) CFO Robert Lawrence Golden Sells 3,000 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Lawrence Golden sold 3,000 shares of the business’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $6.63, for a total transaction of $19,890.00. Following the sale, the chief financial officer owned 91,291 shares of the company’s stock, valued at $605,259.33. This trade represents a 3.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Tuesday, September 15th, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.30, for a total transaction of $18,900.00.

OneMedNet Trading Down 10.8%

OneMedNet stock opened at $4.30 on Friday. The firm has a market capitalization of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14. The firm’s fifty day moving average price is $6.24 and its two-hundred day moving average price is $7.32. OneMedNet Corporation has a 1-year low of $4.30 and a 1-year high of $42.20.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company presently has an average rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.